BPC-157

Common questions about BPC-157

What is BPC-157 and what is it used for?

BPC-157 (Body Protection Compound) is a synthetic 15-amino acid peptide derived from a fragment of a protein found in human gastric juice. It is not FDA approved. It has been studied for tissue repair, mostly in animals. In people, the published studies cover knee pain, interstitial cystitis and ulcerative colitis, and none used injection under the skin (FDA briefing document, pages 42 to 46). Rx Peps Direct providers prescribe BPC-157 as a sterile compounded injectable from a licensed U.S. 503A compounding pharmacy. The 15 mg starter vial is $80 with a $39 medical review.

How much does BPC-157 cost in total?

A first order comes to $134: $80 for the 15 mg vial, $39 for the medical review, and $15 for FedEx overnight shipping. The $80 and the $15 are charged by a licensed U.S. 503A compounding pharmacy, which prices the vial at its wholesale rate with no Rx Peps Direct markup. The $39 is the only charge Rx Peps Direct collects. It is a per-order medical review fee that covers up to three different peptides on the same order. No membership. Automatic refills are optional: they start only if you opt in, and you can turn them off any time from your dashboard. Oral BPC-157 capsules are priced separately at $2.50 per capsule.

Does BPC-157 work for tendon, ligament, and gut healing?

It is not established in people. The tendon, ligament and muscle results come from animals: in one rat study BPC-157 accelerated healing of a cut Achilles tendon (Staresinic and others, 2003). No published study has given BPC-157 to people as an injection under the skin (FDA briefing document, page 44). In a review of patient charts, 11 of 12 people given BPC-157 alone as an injection into the knee joint had significant improvement in knee pain, with no comparison group (Lee and Padgett, 2021). For the gut, one small trial tested an enema in ulcerative colitis, and FDA reviewers concluded there is a lack of evidence to support its effectiveness for that condition (FDA briefing document, page 46). No serious adverse events appear to have been reported in the small human studies, which is not the same as an established safety record. Your provider will discuss what the evidence does and does not support for your situation.

Is BPC-157 legal in the United States?

BPC-157 is not FDA approved, and no compounded medication is. FDA previously placed BPC-157 in Category 2 of its interim list of bulk substances nominated for compounding, the group it says may present significant safety risks. FDA's stated concerns are possible immune reactions with some routes of administration, impurities that are hard to characterize, and little or no safety information in people. FDA now lists BPC-157 among substances whose nominations were withdrawn (its page is dated April 22, 2026), and BPC-157 does not appear in FDA's category list updated May 14, 2026. On July 23, 2026, an FDA advisory committee discussed whether BPC-157 should be added to the list of bulk substances that can be used in compounding under section 503A. FDA's reviewers proposed not adding it. The committee's advice does not bind FDA, and as of October 8, 2026 FDA has not proposed a rule or announced a decision. We will update this page when it does. Rx Peps Direct providers prescribe BPC-157 only as a patient-specific compounded prescription, filled by a licensed U.S. 503A compounding pharmacy. BPC-157 is also named on the World Anti-Doping Agency Prohibited List, so athletes subject to testing should not use it. We keep a dated change log on the BPC-157 FDA status page.

Where do I inject BPC-157, and does the injection site matter?

BPC-157 is injected subcutaneously, meaning under the skin, into the abdomen, upper outer thigh, or back of the upper arm. Do not inject into a joint, tendon or muscle. No human study has compared injection sites, so there is no evidence that injecting near an injury works better. Use a 31-gauge, 5/16-inch (8 mm) needle on a U-100 insulin syringe. Sterile syringes are included with every Rx Peps Direct order.

How much BPC-157 should I take per day?

The Rx Peps Direct starting dose is 20 units (0.6 mg) per injection on a U-100 syringe drawn from a 15 mg / 5 mL vial (3 mg/mL). That is 600 mcg, or 0.2 mL, once daily, Monday to Friday, and one vial lasts five weeks. Your provider sets your dose, and the label on your vial is the authority. No study has tested a dose of BPC-157 injected under the skin in people (FDA briefing document, page 44).

How long does BPC-157 take to work?

No study has measured this. No published study has given BPC-157 to people as an injection under the skin, so there is no evidence-based timeline for when, or whether, an effect appears (FDA briefing document, page 44). One vial covers five weeks at the labeled dose. Tell your provider how you are doing, and they will decide with you whether to continue.

Why does Rx Peps Direct ship BPC-157 as a sterile compounded injectable?

Research-grade BPC-157 powders sold online are not regulated for human use, sterility, or identity verification. Rx Peps Direct prescribes BPC-157 dispensed by a licensed 503A compounding pharmacy in Texas. Batches are tested by Eagle Analytical Services, an FDA-registered and A2LA ISO 17025 accredited independent laboratory, for sterility (ScanRDI or Celsis) and bacterial endotoxin (USP <85>). Published reports are listed on the relevant product page and on the quality page; at present the reports on file cover the BPC-157 combination vials rather than the standalone BPC-157 vial. You can check the lot number on your shipping label against whatever report is published for the product you received, and ask the pharmacy for the certificate covering your specific lot. The vial ships with sterile syringes, alcohol swabs, and a printed protocol sheet at no additional cost.